Jivko Kamarashev

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi request reprint Lymphogranuloma venereum in Zurich, Switzerland: Chlamydia trachomatis serovar L2 proctitis among men who have sex with men
    Jivko Kamarashev
    Department of Dermatology, University Hospital, Zurich, Switzerland
    Swiss Med Wkly 140:209-12. 2010
  2. doi request reprint Symplastic glomus tumor - a rare but distinct benign histological variant with analogy to other 'ancient' benign skin neoplasms
    Jivko Kamarashev
    Department of Dermatology, University Hospital, Zurich, Switzerland
    J Cutan Pathol 36:1099-102. 2009
  3. ncbi request reprint Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation
    Jivko Kamarashev
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Int J Dermatol 46:930-5. 2007
  4. ncbi request reprint Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progression
    Chunlei Zhang
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Hum Pathol 38:995-1002. 2007
  5. ncbi request reprint CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype
    Mirjana Urosevic
    Department of Dermatology, University Hospital Zurich, Zurich 8091, Switzerland
    Hum Pathol 36:1020-4. 2005
  6. doi request reprint Constitutional intraepidermal ascent of melanocytes: a potential pitfall in the diagnosis of melanocytic lesions
    Katrin Kerl
    Department of Dermatology, University Hospital of Zurich, CH 8091 Zurich, Switzerland
    Arch Dermatol 148:235-8. 2012
  7. doi request reprint Spitzoid melanoma and micrometastases in two lymph node regions: a critical situation
    Alexander A Navarini
    Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland
    Eur J Dermatol 21:229-33. 2011
  8. doi request reprint Trauma as triggering factor for development of melanocytic nevi
    Alexander A Navarini
    Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich, Switzerland
    Dermatology 220:291-6. 2010
  9. doi request reprint Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification
    Werner Kempf
    Kempf und Pfaltz Histologische Diagnostik, Zurich, Switzerland
    Am J Dermatopathol 35:159-66. 2013
  10. ncbi request reprint Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2
    Mirjana Urosevic
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Blood 103:1796-8. 2004

Collaborators

Detail Information

Publications20

  1. doi request reprint Lymphogranuloma venereum in Zurich, Switzerland: Chlamydia trachomatis serovar L2 proctitis among men who have sex with men
    Jivko Kamarashev
    Department of Dermatology, University Hospital, Zurich, Switzerland
    Swiss Med Wkly 140:209-12. 2010
    ..Whereas until 2003 Lymphogranuloma venereum (LGV) was rare in industrialised countries, there have been increasing reports of cases of LGV proctitis in men having sex with men (MSM) over the last six years in Europe, America and Australia...
  2. doi request reprint Symplastic glomus tumor - a rare but distinct benign histological variant with analogy to other 'ancient' benign skin neoplasms
    Jivko Kamarashev
    Department of Dermatology, University Hospital, Zurich, Switzerland
    J Cutan Pathol 36:1099-102. 2009
    ..Even prominent cellular atypia and nuclear pleomorphism in a glomus tumor as in our case is not a marker of malignancy in the absence of additional criteria...
  3. ncbi request reprint Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation
    Jivko Kamarashev
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Int J Dermatol 46:930-5. 2007
    ..In order to better understand the dynamics of the disease and the prognostic implications in patients who progress, we studied the duration of each stage and the time at which blast transformation occurred...
  4. ncbi request reprint Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progression
    Chunlei Zhang
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Hum Pathol 38:995-1002. 2007
    ..Thus, cutaneous T-cell lymphoma cells show changes in oncogene and tumor suppressor gene expression that increase proliferation...
  5. ncbi request reprint CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype
    Mirjana Urosevic
    Department of Dermatology, University Hospital Zurich, Zurich 8091, Switzerland
    Hum Pathol 36:1020-4. 2005
    ..MxA protein, representing the surrogate marker for lesional type I interferon activity, was expressed in 4 of 5 evaluated cases. Our findings further substantiate the putative pDC origin of CD4+CD56+ HNs...
  6. doi request reprint Constitutional intraepidermal ascent of melanocytes: a potential pitfall in the diagnosis of melanocytic lesions
    Katrin Kerl
    Department of Dermatology, University Hospital of Zurich, CH 8091 Zurich, Switzerland
    Arch Dermatol 148:235-8. 2012
    ..We discuss the value of TEM for the diagnosis of melanocytic tumors in a young patient previously diagnosed as having 11 cutaneous melanomas...
  7. doi request reprint Spitzoid melanoma and micrometastases in two lymph node regions: a critical situation
    Alexander A Navarini
    Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland
    Eur J Dermatol 21:229-33. 2011
    ..Treatment decisions for atypical Spitz tumors are a major medical and ethical challenge due to the limited available data...
  8. doi request reprint Trauma as triggering factor for development of melanocytic nevi
    Alexander A Navarini
    Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich, Switzerland
    Dermatology 220:291-6. 2010
    ..We conclude that in predisposed patients, the trigger for eruptive nevi can be reduced to a simple localized minor trauma...
  9. doi request reprint Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification
    Werner Kempf
    Kempf und Pfaltz Histologische Diagnostik, Zurich, Switzerland
    Am J Dermatopathol 35:159-66. 2013
    ....
  10. ncbi request reprint Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2
    Mirjana Urosevic
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Blood 103:1796-8. 2004
    ..Together with the expression of IL-10, HLA-G might be one of the factors accounting for the evasion of immunosurveillance, thus contributing to aggressive phenotype of these lymphoma entities...
  11. pmc RASopathic skin eruptions during vemurafenib therapy
    Jeannine D Rinderknecht
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    PLoS ONE 8:e58721. 2013
    ..Cutaneous side effects are frequent. This single-center observational study investigates clinical and histological features of these class-specific cutaneous adverse reactions...
  12. doi request reprint T cell-mediated acute localized exanthematous pustulosis caused by finasteride
    Sandra Tresch
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    J Allergy Clin Immunol 129:589-94. 2012
    ..Within 4 weeks after withdrawal of finasteride, the rash resolved without any specific therapy. Transient discrete residual hyperpigmentation and scaling were present. The patient refused an oral provocation challenge...
  13. doi request reprint Mitogen-activated protein/extracellular signal-regulated kinase kinase inhibition results in biphasic alteration of epidermal homeostasis with keratinocytic apoptosis and pigmentation disorders
    Karin Schad
    University Hospital Zurich, Department of Dermatology, Zurich, Switzerland
    Clin Cancer Res 16:1058-64. 2010
    ..AZD6244 blocks MEK1/2, inhibiting ERK phosphorylation. We focus on associated cutaneous toxicity and we attempt to understand the underlying pathophysiology and design treatment strategies...
  14. ncbi request reprint Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides?
    Reinhard Dummer
    Department of Dermatology, University Hospital, Gloriastrasse 31, CH 8091 Zurich, Switzerland
    Arch Dermatol 138:199-203. 2002
    ..To evaluate the clinical and prognostic features in primary cutaneous CD8+ T-cell lymphomas, which are rare and considered to be aggressive cutaneous lymphoproliferative disorders...
  15. pmc Trichophyton rubrum-induced Majocchi's Granuloma in a heart transplant recipient. A therapeutic challenge
    Urs C Steiner
    Department of Dermatology, University Hospital, Zurich, Switzerland
    J Dermatol Case Rep 6:70-2. 2012
    ..Itraconazole is an anti-fungal compound used for the treatment of infections of the skin, nails and mucous membranes...
  16. ncbi request reprint Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells
    Chun Lei Zhang
    Department of Dermatology, University Hospital of Zurich, CH 8091 Zurich, Switzerland
    J Pathol 200:249-54. 2003
    ..Overexpression of Mcl-1 and synthesis of non-functional Bax may be responsible for the resistance of CTCL cells to the anti-cancer drugs chlorambucil and sulindac...
  17. pmc Treatment of vulvar Paget disease with topical imiquimod: a case report and review of the literature
    Laurence Feldmeyer
    Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland
    J Dermatol Case Rep 5:42-6. 2011
    ..Surgery is considered as the gold standard therapy. In the last years, the topical use of imiquimod cream in the treatment of this condition has been reported...
  18. doi request reprint Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A
    Pietro E Cippà
    Institute of Physiology, University of Zurich, Zurich, Switzerland
    Apoptosis 18:315-23. 2013
    ..The increased efficacy of Bcl-2 inhibitors in combination with cyclosporine A might be relevant to exploit their anti-neoplastic and immuno-modulatory properties...
  19. ncbi request reprint Fascin expression in CD30-positive cutaneous lymphoproliferative disorders
    Werner Kempf
    Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA 02215, USA
    J Cutan Pathol 29:295-300. 2002
    ..Currently there is no marker to predict the development of systemic lymphomas in patients with LyP. Fascin, an actin bundling protein, has recently been shown to be a unique marker found in almost 100% of classical HL...
  20. ncbi request reprint Immunotherapy for murine K1735 melanoma: combinatorial use of recombinant adenovirus expressing CD40L and other immunomodulators
    Isabelle Peter
    Institute of Molecular Biology, University of Zurich, Winterthurerstrasse 190, CH 8057 Zurich, Switzerland
    Cancer Gene Ther 9:597-605. 2002
    ..These results propose that a combination of CD40L plus IL-2 has an improved efficacy over the use of single agents when applied for direct in situ therapy or vaccination therapy...